Andrew Salzman

Andrew Salzman is the Founder and Chairman of the Board at multiple companies, including Salzman Group, Quitsa Pharmaceuticals, Ltd., Beetlebung Pharma Ltd., and Herring Creek Pharmaceuticals, Inc. Andrew also serves as the Founder, Chairman, and Chief Executive Officer at Edgartown Biomedical Labs, Inc. and Elati Corporation. Andrew holds various postdoctoral fellowships from Harvard Medical School and has a Doctor of Medicine degree from Harvard Medical School. Andrew also has a Bachelor of Arts in Psychology from Yale University.